Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system

We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Saade, Elie A., Zhang, Xiaochun, Noguez, Jaime H, Stempak, Lisa M., Tisch, Daniel, Schmotzer, Christine, Salata, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614926/
https://www.ncbi.nlm.nih.gov/pubmed/36310795
http://dx.doi.org/10.1017/ash.2022.29
_version_ 1784820302844264448
author Saade, Elie A.
Zhang, Xiaochun
Noguez, Jaime H
Stempak, Lisa M.
Tisch, Daniel
Schmotzer, Christine
Salata, Robert A.
author_facet Saade, Elie A.
Zhang, Xiaochun
Noguez, Jaime H
Stempak, Lisa M.
Tisch, Daniel
Schmotzer, Christine
Salata, Robert A.
author_sort Saade, Elie A.
collection PubMed
description We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers.
format Online
Article
Text
id pubmed-9614926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-96149262022-10-29 Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system Saade, Elie A. Zhang, Xiaochun Noguez, Jaime H Stempak, Lisa M. Tisch, Daniel Schmotzer, Christine Salata, Robert A. Antimicrob Steward Healthc Epidemiol Concise Communication We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers. Cambridge University Press 2022-03-23 /pmc/articles/PMC9614926/ /pubmed/36310795 http://dx.doi.org/10.1017/ash.2022.29 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Concise Communication
Saade, Elie A.
Zhang, Xiaochun
Noguez, Jaime H
Stempak, Lisa M.
Tisch, Daniel
Schmotzer, Christine
Salata, Robert A.
Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
title Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
title_full Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
title_fullStr Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
title_full_unstemmed Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
title_short Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
title_sort seroprevalence of severe acute respiratory syndrome coronavirus-2 (sars-cov-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614926/
https://www.ncbi.nlm.nih.gov/pubmed/36310795
http://dx.doi.org/10.1017/ash.2022.29
work_keys_str_mv AT saadeeliea seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem
AT zhangxiaochun seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem
AT noguezjaimeh seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem
AT stempaklisam seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem
AT tischdaniel seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem
AT schmotzerchristine seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem
AT salataroberta seroprevalenceofsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthcareproviderspriortothevaccineerainanintegratedmidwesternhealthcaresystem

Ejemplares similares